Mustang Bio, Inc.
Symbol: MBIO (NASDAQ)
1.74
▼ (-2.19%) -0.039
Company Description:
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Key Stats
- Today's Open: $1.78
- Today's High: $1.795
- Today's Low: $1.695
- Today's Volume: 117.62K
- Yesterday Close: $1.78
- Yesterday High: $1.8364
- Yesterday Low: $1.68
- Yesterday Volume: 117.17K
- Last Min Volume: 0
- Last Min High: $1.741
- Last Min Low: $1.741
- Last Min VWAP: $0
Company Profile
- Name: Mustang Bio, Inc.
- Website: https://www.mustangbio.com
- Listed Date: 2017-08-22
- Location: WORCESTER, MA
- Market Status: Active
- CIK Number: 0001680048
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $12.81M
- Round Lot: 100
- Outstanding Shares: 7.24M
- Asset Type: CS
RECENT FILINGS FOR MBIO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-08 | 10-Q | View |
| 2025-07-09 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-09 | SCHEDULE 13G/A | View |
| 2025-04-28 | 4 | View |
| 2025-04-11 | EFFECT | View |
| 2025-04-04 | POS AM | View |
| 2025-04-02 | SCHEDULE 13D/A | View |
| 2025-04-02 | 4 | View |
| 2025-04-01 | POS EX | View |
| 2025-04-01 | 424B3 | View |
| 2025-03-28 | 10-K | View |
| 2025-03-05 | 8-K | View |
| 2025-03-03 | DEF 14C | View |
| 2025-02-27 | 424B3 | View |
| 2025-02-27 | 8-K | View |
| 2025-02-21 | PRE 14C | View |
| 2025-02-21 | 8-K | View |
Latest News on MBIO